Literature DB >> 2926447

The S-100 protein in cerebrospinal fluid: a simple ELISA method.

A Aurell1, L E Rosengren, C Wikkelsø, G Nordberg, K G Haglid.   

Abstract

A simple ELISA method is described for determinations of S-100 protein concentrations in CSF. The assay has a useful range of 200-3200 pmol/l. The precision of the ELISA was estimated using a pool of CSF. The coefficient of variation was 0.18 within assay, 0.17 between assay and 0.17 between day. The S-100 protein is stable in the CSF as no measurable differences in S-100 concentrations were observed in samples stored at room temperature for 2 days. No correlation between age and S-100 concentration was found when determinations were performed in CSF from neurologically healthy males. Furthermore, no changes of S-100 was observed in a lumbocisternal CSF gradient from patients with normal pressure hydrocephalus. Thus, the described ELISA represents an easy to handle and reliable method, well suited for routine determinations of S-100 protein concentration in the CSF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926447     DOI: 10.1016/0022-510x(89)90017-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas.

Authors:  V Wagner; J Rudi; H Näher; W Stremmel
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

2.  Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression.

Authors:  Ludger Tebartz van Elst; Dominique Endres; Maike Michel; Bernd L Fiebich; Hanna Kuzior; Sophie Meixensberger; Benjamin Berger; Simon Maier; Kathrin Nickel; Kimon Runge; Dominik Denzel; Benjamin Pankratz; Miriam A Schiele; Katharina Domschke
Journal:  Transl Psychiatry       Date:  2021-05-21       Impact factor: 6.222

3.  Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.

Authors:  T A Splinter; C F Verkoelen; M Vlastuin; T C Kok; G Rijksen; K G Haglid; F Boomsma; A van de Gaast
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.